Transcat Toekomstige groei

Future criteriumcontroles 1/6

De verwachting is dat Transcat de winst en omzet met respectievelijk 14.9% en 4.8% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 13.2% per jaar.

Belangrijke informatie

14.9%

Groei van de winst

13.2%

Groei van de winst per aandeel

Trade Distributors winstgroei	8.4%
Inkomstengroei	4.8%
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Low
Laatst bijgewerkt	30 Oct 2024

Recente toekomstige groei-updates

Recent updates

There Are Reasons To Feel Uneasy About Transcat's (NASDAQ:TRNS) Returns On Capital

Dec 19

Transcat's (NASDAQ:TRNS) Problems Go Beyond Weak Profit

Nov 08

Capital Allocation Trends At Transcat (NASDAQ:TRNS) Aren't Ideal

Aug 03

Transcat (NASDAQ:TRNS) Hasn't Managed To Accelerate Its Returns

Apr 06

Are Transcat, Inc. (NASDAQ:TRNS) Investors Paying Above The Intrinsic Value?

Oct 20

Transcat acquires Complete Calibrations for $1.2M and e2b Calibration for $3.15M

Sep 28

We Think Transcat (NASDAQ:TRNS) Can Stay On Top Of Its Debt

Aug 05

Transcat (NASDAQ:TRNS) Has Some Way To Go To Become A Multi-Bagger

Jul 24

What Is Transcat, Inc.'s (NASDAQ:TRNS) Share Price Doing?

Jul 13

Is Transcat, Inc. (NASDAQ:TRNS) Trading At A 38% Discount?

Jun 17

Returns At Transcat (NASDAQ:TRNS) Appear To Be Weighed Down

Apr 02

Winst- en omzetgroeiprognoses

NasdaqGM:TRNS - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
3/31/2027	307	26	22	39	2
3/31/2026	295	21	24	40	5
3/31/2025	280	16	18	33	4
9/28/2024	271	18	17	32	N/A
6/29/2024	266	15	20	34	N/A
3/30/2024	259	14	19	33	N/A
12/23/2023	251	10	19	30	N/A
9/23/2023	243	9	18	28	N/A
6/24/2023	237	11	13	22	N/A
3/25/2023	231	11	8	17	N/A
12/24/2022	224	10	8	19	N/A
9/24/2022	218	10	4	15	N/A
6/25/2022	212	11	6	18	N/A
3/26/2022	205	11	7	18	N/A
12/25/2021	198	12	12	20	N/A
9/25/2021	191	12	11	19	N/A
6/26/2021	182	11	15	22	N/A
3/27/2021	173	8	17	24	N/A
12/26/2020	170	7	13	19	N/A
9/26/2020	169	7	16	21	N/A
6/27/2020	170	7	8	15	N/A
3/28/2020	173	8	5	12	N/A
12/28/2019	172	8	7	14	N/A
9/28/2019	170	8	3	11	N/A
6/29/2019	167	7	4	10	N/A
3/30/2019	161	7	6	13	N/A
12/29/2018	159	7	5	11	N/A
9/29/2018	158	7	7	13	N/A
6/30/2018	156	6	N/A	16	N/A
3/31/2018	155	6	N/A	10	N/A
12/23/2017	151	5	N/A	9	N/A
9/23/2017	148	4	N/A	4	N/A
6/24/2017	147	4	N/A	5	N/A
3/25/2017	144	5	N/A	8	N/A
12/24/2016	138	5	N/A	7	N/A
9/24/2016	131	4	N/A	11	N/A
6/25/2016	126	4	N/A	8	N/A
3/26/2016	122	4	N/A	11	N/A
12/26/2015	122	4	N/A	11	N/A
9/26/2015	123	4	N/A	10	N/A
6/27/2015	124	4	N/A	9	N/A
3/28/2015	124	4	N/A	4	N/A
12/27/2014	122	4	N/A	5	N/A
9/27/2014	121	4	N/A	7	N/A
6/28/2014	119	4	N/A	6	N/A
3/29/2014	119	4	N/A	8	N/A
12/28/2013	119	4	N/A	7	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei TRNS ( 14.9% per jaar) ligt boven de spaarquote ( 2.5% ).

Winst versus markt: De winst van TRNS ( 14.9% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.2% per jaar).

Hoge groeiwinsten: De winst van TRNS zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van TRNS ( 4.8% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.8% per jaar).

Hoge groei-inkomsten: De omzet van TRNS ( 4.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van TRNS naar verwachting over 3 jaar hoog zal zijn

Transcat Toekomstige groei

Future criteriumcontroles 1/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 10% to US$119

Transcat, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Consensus EPS estimates fall by 21%

Transcat, Inc. Provides Financial Guidance for the Fiscal Year 2024

Consensus EPS estimates increase by 10%

Price target increased by 9.5% to US$92.60

Recent updates

Transcat, Inc. to Report Q2, 2025 Results on Oct 28, 2024

Transcat: Growth Is Great, But Not Enough To Prevent A Bearish Outlook

Does Transcat (NASDAQ:TRNS) Deserve A Spot On Your Watchlist?

Market Participants Recognise Transcat, Inc.'s (NASDAQ:TRNS) Earnings

Transcat, Inc. to Report Q1, 2025 Results on Jul 29, 2024

Transcat, Inc., Annual General Meeting, Sep 11, 2024

Transcat (NASDAQ:TRNS) Might Be Having Difficulty Using Its Capital Effectively

Transcat (NASDAQ:TRNS) Ticks All The Boxes When It Comes To Earnings Growth

Transcat's (NASDAQ:TRNS) Promising Earnings May Rest On Soft Foundations

President recently sold US$415k worth of stock

Full year 2024 earnings released: EPS: US$1.66 (vs US$1.42 in FY 2023)

Does Transcat (NASDAQ:TRNS) Have A Healthy Balance Sheet?

Transcat, Inc. to Report Q4, 2024 Results on May 20, 2024

Some Confidence Is Lacking In Transcat, Inc.'s (NASDAQ:TRNS) P/S

Transcat, Inc. (NasdaqGM:TRNS) acquired Becnel Rental Tools, LLC for $50 million.

Transcat Stock: Time To Recalibrate

Transcat, Inc. (NasdaqGM:TRNS) acquired Becnel Rental Tools, LLC for $50 million.

Transcat, Inc. Announces Management Changes

President exercised options and sold US$439k worth of stock

President recently sold US$1.1m worth of stock

President notifies of intention to sell stock

Price target increased by 10% to US$119

Transcat Scores Wins On The Top And Bottom Lines, But Is Still Too Expensive

Transcat, Inc. Announces Board Changes

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Transcat, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Transcat, Inc. to Report Q3, 2024 Results on Jan 29, 2024

There Are Reasons To Feel Uneasy About Transcat's (NASDAQ:TRNS) Returns On Capital

President notifies of intention to sell stock

Independent Director recently bought US$100k worth of stock

Transcat's (NASDAQ:TRNS) Problems Go Beyond Weak Profit

Consensus EPS estimates fall by 21%

New minor risk - Earnings quality

High number of new directors

Transcat, Inc. Appoints Dawn DePerrior to the Board

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Transcat, Inc. Provides Financial Guidance for the Fiscal Year 2024

Transcat, Inc. to Report Q2, 2024 Results on Oct 30, 2023

Chief Operating Officer exercised options and sold US$144k worth of stock

Transcat, Inc. has completed a Follow-on Equity Offering in the amount of $70.000275 million.

Transcat, Inc. has completed a Follow-on Equity Offering in the amount of $70.000275 million.

Investor sentiment deteriorates as stock falls 16%

New minor risk - Shareholder dilution

President recently sold US$264k worth of stock

President notifies of intention to sell stock

Consensus EPS estimates increase by 10%

Transcat, Inc. (NasdaqGM:TRNS) acquired Axiom Test Equipment, Inc. for $38 million.

Capital Allocation Trends At Transcat (NASDAQ:TRNS) Aren't Ideal

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Transcat, Inc., Annual General Meeting, Sep 06, 2023

Transcat, Inc. to Report Q1, 2024 Results on Jul 31, 2023

Independent Director recently sold US$301k worth of stock

Full year 2023 earnings released: EPS: US$1.42 (vs US$1.52 in FY 2022)

Transcat, Inc. to Report Q4, 2023 Results on May 22, 2023

Transcat (NASDAQ:TRNS) Hasn't Managed To Accelerate Its Returns

Insider recently sold US$90k worth of stock

Independent Director recently sold US$436k worth of stock

Price target increased by 9.5% to US$92.60

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Transcat, Inc. to Report Q3, 2023 Results on Jan 30, 2023

Consensus forecasts updated

Independent Director recently sold US$181k worth of stock

Price target increased to US$86.60

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Are Transcat, Inc. (NASDAQ:TRNS) Investors Paying Above The Intrinsic Value?

Transcat, Inc. to Report Q2, 2023 Results on Oct 31, 2022

Investor sentiment improved over the past week

Transcat, Inc. (NasdaqGM:TRNS) acquired Galium Limited for $1.2 million.

Transcat acquires Complete Calibrations for $1.2M and e2b Calibration for $3.15M